Jonathan Dow is the Senior Program Manager for the MSK Therapeutics Accelerator, based in MSK’s Office of Technology Development. He joined MSK in 2024.
Previously, Jonathan was a consultant with ClearView Healthcare Partners, where he advised biopharma clients on oncology engagements, including strategic portfolio planning and early-stage opportunity assessments. He earlier served as a Business Development Associate at AtlasXomics, and as the Blavatnik Technology Transfer Associate at the Yale Office of Cooperative Research.
Jonathan received his Ph.D. in Genetics from Yale University. He also holds a B.Sc. degree in Biology from Brown University.